These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2352480

  • 21. The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia.
    Segawa M, Hirata Y, Fujimori S, Okada K.
    Metabolism; 1988 May; 37(5):454-60. PubMed ID: 3285132
    [Abstract] [Full Text] [Related]

  • 22. Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
    Kumar S, Arun KH, Kaul CL, Sharma SS.
    Neurol Res; 2005 Jan; 27(1):60-6. PubMed ID: 15829161
    [Abstract] [Full Text] [Related]

  • 23. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ, Sarges R, Aldinger CE, MacDonald DP.
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [Abstract] [Full Text] [Related]

  • 24. Transition metals and polyol pathway in the development of diabetic neuropathy in rats.
    Nakamura J, Hamada Y, Chaya S, Nakashima E, Naruse K, Kato K, Yasuda Y, Kamiya H, Sakakibara F, Koh N, Hotta N.
    Diabetes Metab Res Rev; 2002 Apr; 18(5):395-402. PubMed ID: 12397582
    [Abstract] [Full Text] [Related]

  • 25. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H, Tawata M, Aida K, Onaya T.
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T, Nakamura J, Koh N, Sakakibara F, Hamada Y, Sasaki H, Naruse K, Nakashima E, Takeuchi N, Inukai S.
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [Abstract] [Full Text] [Related]

  • 33. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA, Cameron NE, Hohman TC.
    J Peripher Nerv Syst; 1998 Dec; 3(3):217-23. PubMed ID: 10959252
    [Abstract] [Full Text] [Related]

  • 34. Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosine.
    Saini AK, Arun KH, Kaul CL, Sharma SS.
    Pharmacol Res; 2004 Dec; 50(6):593-9. PubMed ID: 15501697
    [Abstract] [Full Text] [Related]

  • 35. Effects of the peptide HP228 on nerve disorders in diabetic rats.
    Calcutt NA, Dines KC, Ceseña RM.
    Metabolism; 1998 Jun; 47(6):650-6. PubMed ID: 9627361
    [Abstract] [Full Text] [Related]

  • 36. Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats.
    Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Komori H, Sakamoto N.
    Diabetes; 1992 May; 41(5):587-91. PubMed ID: 1533192
    [Abstract] [Full Text] [Related]

  • 37. Nerve conduction and antioxidant levels in experimentally diabetic rats: effects of streptozotocin dose and diabetes duration.
    Van Dam PS, Van Asbeck BS, Bravenboer B, Van Oirschot JF, Marx JJ, Gispen WH.
    Metabolism; 1999 Apr; 48(4):442-7. PubMed ID: 10206435
    [Abstract] [Full Text] [Related]

  • 38. Galactosemic neuropathy in transgenic mice for human aldose reductase.
    Yagihashi S, Yamagishi S, Wada R, Sugimoto K, Baba M, Wong HG, Fujimoto J, Nishimura C, Kokai Y.
    Diabetes; 1996 Jan; 45(1):56-9. PubMed ID: 8522060
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.